Arkolith/Insider Trading/SGTX/Form 4

Anderson Daniel Griffith

DirectorSigilon Therapeutics, Inc. (SGTX) · full profile →Form 4 · filed Jun 4, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.0M
Net Open-Market Flow
-$2.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2021Sell(S)200K$10.00$2.0M2.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-21-002817) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML